Letter: Trump does deserve some credit for vaccine

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Jim Shella asserts that Pfizer was not part of Operation Warp Speed and therefore President Trump’s administration had no role in their vaccine development [Trump doesn’t deserve credit for COVID vaccine, Forefront, Dec. 11]. While they may not have taken money up front, they had a contract to purchase a vaccine in advance of the development for $2 billion for 100 million doses with the rights to purchase 500 million more for an additional $8 billion. The U.S. government guaranteed Pfizer a market for their product should they be able to develop it. So, did the Trump administration facilitate the development? Absolutely. Did the Trump administration take down barriers to approvals that normally take years? Absolutely. Is President Trump solely responsible for the vaccine development? Absolutely NOT.

The federal government created an expedited pathway that lowered the cost of development to the pharmaceutical companies, guaranteed them a market to sell their product, and therefore it was a team effort. In my opinion it was one of the best public-private partnerships to achieve a goal as quick as possible. When President Trump said months ago that there would be a vaccine before Christmas, those who disagree with him laughed at him and said another crazy prediction. What are they saying now?

Should Trump say it is all because of him? Of course not. Should Pfizer say they accomplished this all on their own? No, they should not.

Granted, the Pfizer scientists are some of the smartest people in the world, and I am grateful to every one of them. They did take a risk, because if they ultimately failed to deliver a product, then they would spend all the money in vain. But they are smart businesspeople as well and ran the numbers and calculated the risk, and with the federal government guarantee of the $8 billion in purchases, they felt the risk was worth it and they were right.

Mr. Shella is as much wrong as President Trump in saying who the credit should go to. Everyone involved needs to come together and say “great work” by all parties to accomplish this tremendous goal!

__________

H. Todd Hoopingarner
President
Solutions Healthcare Management

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “Letter: Trump does deserve some credit for vaccine

  1. Having a vaccine is great. Having everyone vaccinated is differnt story. I suspect we will see another big failure when it comes to makeing sure everything is/was in place for the distribution that we won’t see start to untangle until after January 21st. 2021.

  2. What we have a vaccine being distributed and administered, that can’t be. Joe said he needed to be making those, you know the thing, the decisions, think about it man!

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In